Table 1. Correlation between NNT-AS1 expression and clinical parameters of patients with bladder cancer.
Clinical parameters | NNT-AS1 expression | P | |
High | Low | ||
Age (years) | 0.461 | ||
< 60 | 18 (75.0%) | 20 (87.0%) | |
≥ 60 | 6 (25.0%) | 3 (13.0%) | |
Gender | 0.534 | ||
Male | 15 (62.5%) | 17 (73.9%) | |
Female | 9 (37.5%) | 6 (26.1%) | |
Histologic grade | 0.212 | ||
Low grade | 10 (41.7%) | 5 (21.7%) | |
High grade | 14 (58.3%) | 18 (78.3%) | |
Lymphatic invasion | 0.017 | ||
Negative | 14 (58.3%) | 21 (91.3%) | |
Positive | 10 (41.7%) | 2 (8.7%) | |
TNM stage | 0.015 | ||
I-II | 11 (45.8%) | 19 (82.6%) | |
III-IV | 13 (54.2%) | 4 (17.4%) | |
Smoking | 0.380 | ||
Nonsmoking | 12 (50.0%) | 15 (65.2%) | |
Smoking | 12 (50.0%) | 8 (34.8%) |